We are live on
!
Find out more
AXDX
Accelerate Diagnostics
AXDX
AXDX
Delisted
AXDX was delisted on the 14th of May, 2025.
119 hedge funds and large institutions have $612M invested in Accelerate Diagnostics in 2018 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 40 increasing their positions, 27 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
80% more call options, than puts
Call options by funds: $27.3M | Put options by funds: $15.1M
48% more repeat investments, than reductions
Existing positions increased: 40 | Existing positions reduced: 27
22% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 9
11% more capital invested
Capital invested by funds: $552M → $612M (+$60.8M)
2% more funds holding
Funds holding: 117 → 119 (+2)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Holders
119
Holders Change
+2
Holders Change %
+1.71%
% of All Funds
2.72%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
11
Increased
40
Reduced
27
Closed
9
Calls
$27.3M
Puts
$15.1M
Net Calls
+$12.1M
Net Calls Change
+$2.66M
Top Buyers
Top Sellers
| 1 |
OIM
Oracle Investment Management
Greenwich,
Connecticut
|
-$1.92M |
| 2 |
Wells Fargo
San Francisco,
California
|
-$1.38M |
| 3 |
Morgan Stanley
New York
|
-$894K |
| 4 |
Daiwa Securities Group
Tokyo,
Japan
|
-$774K |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
-$750K |
